Related Experiment Videos
The detection and interpretation of endotoxaemia
1Department of Infectious Diseases, Imperial College School of Medicine, Hammersmith Hospital, London, UK. j.cohen@ic.ac.uk
Intensive Care Medicine
|April 29, 2000
Summary
Measuring endotoxin using the Limulus amoebocyte lysate (LAL) assay is not recommended for routine clinical practice. Despite potential in diagnosing Gram-negative infections, the LAL assay shows poor precision and accuracy, leading to unreliable results.
Area of Science:
- Microbiology
- Immunology
- Clinical Pathology
Background:
- Endotoxin plays a role in sepsis pathogenesis.
- Gram-negative infections require timely diagnosis.
- The Limulus amoebocyte lysate (LAL) assay measures endotoxin, a potential biomarker.
Purpose of the Study:
- To evaluate the clinical utility of endotoxin measurement as a surrogate marker for Gram-negative infections.
- To assess the accuracy and reliability of the LAL assay in clinical practice.
Main Methods:
- Review of existing evidence on endotoxin measurement in sepsis.
- Analysis of the performance characteristics of the LAL assay, including precision, accuracy, and predictive values.
Main Results:
- Endotoxemia is detected in approximately 30% of patients with bacteremia.
- Endotoxemia does not reliably predict Gram-negative bacteremia, infection, or sepsis survival.
- The LAL assay exhibits limitations including contamination risks, poor precision, and potential for false results.
- The positive predictive value of endotoxin testing is insufficient for clinical use.
Conclusions:
- Routine endotoxin testing is not currently recommended in clinical practice.
- The LAL assay's limitations hinder its use in diagnosing Gram-negative infections.
- Further research is needed to determine if the LAL assay or newer developments can reliably exclude Gram-negative infections.